Lakewood-Amedex Biotherapeutics

Lakewood-Amedex Advances Nu-3 Gel Toward Phase 2a Trial

SARASOTA, Fla., July 15, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced encouraging preclinical safety results supporting dose selection for the...

By cGxPwire Editor
July 17, 2026

Pharma

Saol Therapeutics Resubmits NDA for SL1009 in PDCD

ROSWELL, Ga., DUBLIN, Ireland & HAMILTON, Bermuda, July 7, 2026 Saol Therapeutics has announced the resubmission of its New...

By cGxPwire Editor
July 7, 2026

Pharma

Lakewood-Amedex Backs PASTEUR Act to Fight AMR Crisis

SARASOTA, Fla., July 7, 2026 Lakewood-Amedex Biotherapeutics has announced its support for the reintroduction of the bipartisan Pioneering Antimicrobial...